the percentage of the hypoperfused zone that evolved to infarction was 96 +/- 3 % ( mean +/- sem ) in control dogs , 74 +/- 4 % in dogs treated with nicotinic acid ( p less than 0.05 vs control dogs ) , 72 +/- 2 % in dogs treated with oxfenicine ( p less than 0.05 vs control dogs ) , and 54 +/- 5 % in dogs with combined nicotinic acid and oxfenicine ( p less than 0.05 vs control dogs , p less than 0.05 vs nicotinic acid and oxfenicine ) .
C0022116
hypoperfused
C0021308
infarction